102 related articles for article (PubMed ID: 15150612)
1. Loss of NOS1 expression in high-grade renal cell carcinoma associated with a shift of NO signalling.
Renaudin K; Denis MG; Karam G; Vallette G; Buzelin F; Laboisse CL; Jarry A
Br J Cancer; 2004 Jun; 90(12):2364-9. PubMed ID: 15150612
[TBL] [Abstract][Full Text] [Related]
2. Expression of NOS1 and soluble guanylyl cyclase by human kidney epithelial cells: morphological evidence for an autocrine/paracrine action of nitric oxide.
Jarry A; Renaudin K; Denis MG; Robard M; Buffin-Meyer B; Karam G; Buzelin F; Paris H; Laboisse CL; Vallette G
Kidney Int; 2003 Jul; 64(1):170-80. PubMed ID: 12787407
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide pathways in human bladder carcinoma. The distribution of nitric oxide synthases, soluble guanylyl cyclase, cyclic guanosine monophosphate, and nitrotyrosine.
Ehsan A; Sommer F; Schmidt A; Klotz T; Koslowski J; Niggemann S; Jacobs G; Engelmann U; Addicks K; Bloch W
Cancer; 2002 Dec; 95(11):2293-301. PubMed ID: 12436434
[TBL] [Abstract][Full Text] [Related]
4. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
Hemmerlein B; Galuschka L; Putzer N; Zischkau S; Heuser M
Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
Raman JD; Mongan NP; Liu L; Tickoo SK; Nanus DM; Scherr DS; Gudas LJ
Carcinogenesis; 2006 Mar; 27(3):499-507. PubMed ID: 16344273
[TBL] [Abstract][Full Text] [Related]
7. Expression of regulator of G protein signalling protein 5 (RGS5) in the tumour vasculature of human renal cell carcinoma.
Furuya M; Nishiyama M; Kimura S; Suyama T; Naya Y; Ito H; Nikaido T; Ishikura H
J Pathol; 2004 May; 203(1):551-8. PubMed ID: 15095478
[TBL] [Abstract][Full Text] [Related]
8. Down-regulated expression of RhoA in human conventional renal cell carcinoma.
Pu YS; Wang CW; Liu GY; Kuo YZ; Huang CY; Kang WY; Shun CT; Lin CC; Wu WJ; Hour TC
Anticancer Res; 2008; 28(4B):2039-43. PubMed ID: 18751372
[TBL] [Abstract][Full Text] [Related]
9. The role of nitric oxide in the local antiallodynic and antihyperalgesic effects and expression of delta-opioid and cannabinoid-2 receptors during neuropathic pain in mice.
Hervera A; Negrete R; Leánez S; Martín-Campos J; Pol O
J Pharmacol Exp Ther; 2010 Sep; 334(3):887-96. PubMed ID: 20498253
[TBL] [Abstract][Full Text] [Related]
10. Expression of nitric oxide synthase and nitric oxide-sensitive guanylate cyclase in the crustacean cardiac ganglion.
Scholz NL; Labenia JS; de Vente J; Graubard K; Goy MF
J Comp Neurol; 2002 Dec; 454(2):158-67. PubMed ID: 12412140
[TBL] [Abstract][Full Text] [Related]
11. Differentiation between normal renal tissue and renal tumours using functional optical coherence tomography: a phase I in vivo human study.
Barwari K; de Bruin DM; Faber DJ; van Leeuwen TG; de la Rosette JJ; Laguna MP
BJU Int; 2012 Oct; 110(8 Pt B):E415-20. PubMed ID: 22574685
[TBL] [Abstract][Full Text] [Related]
12. Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.
Lv D; Zhao W; Dong D; Qian XP; Zhang Y; Tian XJ; Zhang J
Eur J Cancer; 2011 Sep; 47(13):2068-76. PubMed ID: 21600761
[TBL] [Abstract][Full Text] [Related]
13. Expression of Ksp-cadherin during kidney development and in renal cell carcinoma.
Thedieck C; Kuczyk M; Klingel K; Steiert I; Müller CA; Klein G
Br J Cancer; 2005 Jun; 92(11):2010-7. PubMed ID: 15886705
[TBL] [Abstract][Full Text] [Related]
14. Loss of expression of growth differentiation factor-9 (GDF9) in human kidney cancer and regulation of growth and migration of kidney cancer cells by GDF9.
Du P; Ye L; Li H; Ruge F; Yang Y; Jiang WG
Anticancer Res; 2012 Oct; 32(10):4375-83. PubMed ID: 23060562
[TBL] [Abstract][Full Text] [Related]
15. Elements of the nitric oxide/cGMP pathway expressed in cerebellar granule cells: biochemical and functional characterisation.
Jurado S; Sánchez-Prieto J; Torres M
Neurochem Int; 2004 Nov; 45(6):833-43. PubMed ID: 15312977
[TBL] [Abstract][Full Text] [Related]
16. Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour.
Tse GM; Wong FC; Tsang AK; Lee CS; Lui PC; Lo AW; Law BK; Scolyer RA; Karim RZ; Putti TC
J Clin Pathol; 2005 Jun; 58(6):600-4. PubMed ID: 15917410
[TBL] [Abstract][Full Text] [Related]
17. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
18. Localization of constitutive nitric oxide synthase isoforms and the nitric oxide target enzyme soluble guanylyl cyclase in the human bladder.
Fathian-Sabet B; Bloch W; Klotz T; Niggemann S; Jacobs G; Addicks K; Engelmann U
J Urol; 2001 May; 165(5):1724-9. PubMed ID: 11342964
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells.
Baltrons MA; García A
J Neurochem; 1999 Nov; 73(5):2149-57. PubMed ID: 10537075
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of facilitative glucose transporters in normal and tumour kidney tissues.
Suganuma N; Segade F; Matsuzu K; Bowden DW
BJU Int; 2007 May; 99(5):1143-9. PubMed ID: 17437443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
